Cambridge Nutritional Sciences plc (AIM:CNSL)
London · Delayed Price · Currency is GBP · Price in GBX 1.900
+0.150 (8.57%)
Jun 19, 2026, 4:20 PM GMT
AIM:CNSL Market Cap
AIM:CNSL has a market cap or net worth of 4.16 million as of June 18, 2026. Its market cap has decreased by -45.31% in one year.
Market Cap
4.16M
Enterprise Value
807.14K
Revenue
8.06M
Ranking
n/a
PE Ratio
3.05
Stock Price
1.90
Market Cap Chart
Since December 7, 2007, AIM:CNSL's market cap has increased from 3.12M to 4.16M, an increase of 33.30%. That is a compound annual growth rate of 1.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 4.16M | -10.26% |
| Dec 31, 2025 | 4.64M | -29.09% |
| Dec 31, 2024 | 6.54M | 14.71% |
| Dec 29, 2023 | 5.70M | -36.00% |
| Dec 30, 2022 | 8.91M | -82.10% |
| Dec 31, 2021 | 49.78M | -57.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 205.26B |
| GSK plc | 76.72B |
| Haleon | 29.49B |
| Smith & Nephew | 9.55B |
| Proteome Sciences | 5.30M |
| Theracryf | 5.05M |
| Nuformix | 4.83M |
| Thalia Therapeutics | 4.79M |